Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan.
Jer-Hwa ChangJeng-Fong ChiouChing-Sheng HungMing-Che LiuHui-Wen ChangShiao-Ya HongCheng-Yi WangYi-Ling LinYi-Chen HsiehChi-Li ChungYing-Shih SuShu-Tai Shen HsiaoDoresses LiuJian-Jong LiangChun-Che LiaoChih-Shin ChangKevin Shu-Leung LaiHan-Chuan ChuangKo-Ling ChienWei-Ciao WuYuan-Chii Gladys LeeSey-En LinYung-Kang ShenChiung-Fang HsuJude Chu-Chun WangShih-Hsin HsiaoPublished in: Vaccines (2022)
The vaccine is well-tolerated and elicited robust humoral immunity against SARS-CoV-2 after standard prime-boost vaccination in Taiwanese recipients.